Extends the Company’s Patent Estate for its Nano-based LSPR Platform MENLO PARK, CA, April 24, 2013 — LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the United State Patent and Continue reading →

MENLO PARK, CA — LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the Japanese Patent Office issuance of patent number 5203390, “Enzymatic Assays for LSPR”, which enables highly sensitive and Continue reading →